Nordstrom Removes Clothing Line That Features Prescription Bottle Purses, Pill-Decorated Dresses
Just because a high-end fashion designer makes a purse that looks like a pill bottle doesn’t mean consumers are going to find it any less controversial than the syringe pens sold at Target or the prescription pill bottle shot glasses from Urban Outfitters. For that reason, Nordstrom says it will no longer sell a line of clothing from Italian designer Moschino.
The Minneapolis Star Tribune reports that Nordstrom has pulled the designs — which also feature a dress covered in pill capsules — from stores after consumers started a petition accusing the company of ignoring the national drug epidemic.
An official for Nordstrom confirmed that it would no longer sell the high-end “Capsule” line from Moschino that was introduced during New York 2016 Fashion Week.
Saks, which also sells the Moschino line, did not respond to the Tribune’s request for comment on possibly pulling the designs.
An alcohol and drug counselor who started the online petition last weekend tells the Tribune that the company’s decision to remove the line was a victory, noting that his concern was centered on the retailer and fashion line’s apparent unmindfulness about drug issues in the U.S.
The collection, which was inspired by the packaging and instructional inserts of over-the-counter medication, ranges from a $950 prescription bottle purse and a $650 short black dress covered in colorful pills, to a $1,095 pill-package-inspired pursue and a $175 pill-decorated umbrella.
While the items aren’t quite on par with the “Hairroin” hypodermic needle pens once sold at Urban Outfitters, the counselor points out that even prescription drugs have come to the forefront of drug issues. He notes that many people who became addicted to opioids started with a legal prescription from a physician after an injury or medical procedure.
Nordstrom reverses course, yanks controversial drug-themed clothing by Moschino [The Minneapolis Star Tribune]
Want more consumer news? Visit our parent organization, Consumer Reports, for the latest on scams, recalls, and other consumer issues.
